IMRAN TALAT (Chief Executive Officer) purchased 1.1% of their position (5K shares) of RANI THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $10.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/9/2023ACC: 0000950170-23-062001
DirectorOfficer· Chief Executive Officer
Since Jul 2021
+5K
Net shares
Net buyer
$10.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+2.50K
Price / share
$1.98
Trade value
$4.95K
% of position
0.6%
11/7/2023
444.45K→446.95K
Class A Common Stock
Direct
Shares
+2.50K
Price / share
$2.01
Trade value
$5.02K
% of position
0.6%
11/7/2023
446.95K→449.45K
Total
Net shares
+5K
Net value
$9.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/7/2023 | P · Purchase | +2.50K | $1.98 | $4.95K | 0.6% | 444.45K | 446.95K |
| Class A Common Stock Direct | 11/7/2023 | P · Purchase | +2.50K | $2.01 | $5.02K | 0.6% | 446.95K | 449.45K |
| Total | +5K | $9.97K | ||||||
Derivative Transactions0
No derivative transactions reported